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Abstract
Background: In veterinary medicine and animal husbandry, there is a need for tools allowing the early warning of
diseases. Preferably, tests should be available that warn farmers and veterinarians during the incubation periods of
disease and before the onset of clinical signs. The objective of this study was to explore the potential of serum
protein profiles as an early biomarker for infectious disease status. Serum samples were obtained from an
experimental pig model for porcine circovirus-associated disease (PCVAD), consisting of Porcine Circovirus type 2
(PCV2) infection in combination with either Porcine Parvovirus (PPV) or Porcine Reproductive and Respiratory
Syndrome virus (PRRSV). Sera were collected before and after onset of clinical signs at day 0, 5 and 19 post
infection. Serum protein profiles were evaluated against sera from non-infected control animals.
Results: Protein profiles were generated by SELDI-TOF mass spectrometry in combination with the Proteominer™
technology to enrich for low-abundance proteins. Based on these protein profiles, the experimentally infected pigs
could be classified according to their infectious disease status. Before the onset of clinical signs 88% of the
infected animals could be classified correctly, after the onset of clinical sigs 93%. The sensitivity of the classification
appeared to be high. The protein profiles could distinguish between separate infection models, although specificity
was moderate to low. Classification of PCV2/PRRSV infected animals was superior compared to PCV2/PPV infected
animals. Limiting the number of proteins in the profiles (ranging from 568 to 10) had only minor effects on the
classification performance.
Conclusions: This study shows that serum protein profiles have potential for detection and identification of viral
infections in pigs before clinical signs of the disease become visible.
Background
In present livestock husbandry with increasing require-
ments for higher health and welfare issues but also tight
economical margins, there is a need for tools allowing the
early warning for disease. Ideally, easy to perform tools
should be available that warn farmers and veterinarians
that animals are infected, preferably before the onset of
clinical signs. Regular use of such tools may diminish
growth retardations and production losses. However, tests
for early diagnosis can only be developed when animal-
associated “biomarkers” exist that differ between unin-
fected healthy animals and infected, but not yet diseased,
animals. The search for such biomarkers can be performed
by two different approaches, either focusing on differences
in predefined “candidate” markers, or by comparative fin-
gerprint analysis of “all” components present in a biologi-
cal sample.
In human medicine extensive research has been per-
formed aiming at the discovery of early biomarkers for dif-
ferent kinds of disease, including cancer. Early diagnosis is
important because of increased treatment options and bet-
ter prognosis when treatments are initiated at an earlier
stage [1-3]. In such settings, involving alteration of several
pathways and processes, it has been suggested that multi-
ple marker assays lead to an increase in clinical sensitivity
and specificity relative to single-marker assays [4]. Also for
the early detection of infections in veterinary medicine it
has been shown that a combination of protein biomarkers
increases the performance, i.e. for transmissible spongi-
form encephalopathies (TSEs), paratuberculosis, Dichelo-
bacternodosus and Fasciola hepatica [5-9].
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human and animal diseases has been facilitated by proteo-
mic analysis, some of which have already been commercia-
lized [10]. Comparative proteomic analyses can be
performed relatively easily using surface enhanced laser
desorption/ionization time-of-flight mass spectrometry
(SELDI-TOF-MS) [11]. SELDI-TOF-MS technology
includes the use of protein chip arrays that specifically
bind intact proteins present in biological samples, such as
body fluids or tissue extracts. Arrays may vary in their sur-
face chemistry, for instance they may have hydrophobic or
hydrophilic properties, thereby selectively binding pro-
teins. Protein components are solely identified by their
specific molecular weights. By comparing SELDI-TOF-MS
profiles, protein components that differ in abundance
between (groups of) samples can be recognized.
SELDI-TOF-MS generates a profile of peaks represent-
ing the relative abundance of each protein component
retained on the chip and has a high specificity in distin-
guishing (groups of) samples. This is especially true when
used in combination with a technology to enrich low-
a b u n d a n tp r o t e i n s ,i . e .t h eP r o t e o m i n e r ™ technology,
which is based on affinity chromatography using a solid
phase combinatorial peptide ligand library. The latter
leads to a reduction of the dynamic range of plasma pro-
tein concentrations and an improved access to low abun-
dant proteins. The combination of these technologies
provides protein profiles representing the relative concen-
trations of a large number of high- and low-abundant pro-
teins in a biological sample [12,13]. In addition, this
technology can be used at a medium throughput scale.
To assess the potential of serum protein profiles as a
diagnostic marker for viral infectious diseases in pigs, we
used an experimental animal model for porcine circovirus-
associated disease (PCVD), an important swine disease
mostly known in the manifestation of postweaningmulti-
systemic wasting syndrome (PMWS). It is, at present, one
of the most economically important diseases in swine
industry. Although Porcine Circovirus type 2 (PCV2) is
regarded as the primary causative agent, PCVD is consid-
ered a multifactorial disease. PCV2 pathogenesis appears
to be related to the immune-modulatory effects of the
virus while other micro-organisms contribute to the clini-
cal signs associated with PCVD. Both porcine parvovirus
(PPV) and porcine reproductive and respiratory syndrome
virus (PRRSV) have been shown to be associated as co-fac-
tors. Experimental co-infections of PPV or PRRSV with
PCV2 have fully reproduced PCVAD. These data have
been supported by field data in which these viruses have
been isolated in association with PMWS [14].
The objective of this study was to explore the potential
of serum protein profiles consisting of both high- and
low-abundant proteins, as measured by SELDI-TOF-MS,
for the diagnosis of early infectious disease status in pigs.
To this end the serum protein profiles, obtained from
experimentally infected PCV2/PPV, PCV2/PRRSV, and
control animals were used to investigate the classification
accuracy for different comparisons, i.e. infected versus
non-infected, PCV2/PPV versus control, PCV2/PRRSV
versus control, and the three-way classification PCV2/
PPV, PCV2/PRRSV, and control. In addition, we investi-
gated the classification performance of subsets of protein
profiles that varied in the number of used protein
components.
Results
Clinical signs and pathology
During the course of the experiment, all pigs infected with
PCV2 in combination with either PPV or PRRSV devel-
oped clinical disease signs with a varying degree of sever-
ity. No systemic disease signs were observed in the control
group with the exception of a temporary lameness in one
pig and paleness in two pigs. Three pigs in the PCV2/
PRRSV infected group and one pig from the PCV2/PPV
infected group were euthanized for humane reasons at
25 and 26 days post infection. Two pigs died directly after
blood sampling, supposedly not related to the experimen-
tal infection; one from the control group (at 18 days post
infection) and another pig from the PCV2/PRRSV group
(at 12 days post infection).
Pigs in both the PCV2/PRRSV and the PCV2/PPV
infected groups showed signs of wasting with a significant
difference in weekly body weight gain compared to the
control group. This was consistently seen starting at one
week post infection (p < 0.001 and p < 0.05, respectively).
Body weight gain was significantly lower in the PCV2/
PRRSV infected group compared to the PCV2/PPV
infected group in the first week post infection. In the sec-
ond week post infection, weight gain was similar in both
infected groups. Data are shown in Figure 1A.
Mean rectal temperature in pigs in the PCV2/PRRSV
infected group increased to febrile temperatures, i.e. rectal
temperatures ≥ 40.0°C from two days post infection on for
seven days and again elevated mean body temperatures
were seen at 14 days post infection and for a period of five
days between 18 and 23 days post infection (Figure 1B). In
the PCV2/PPV infected group febrile body temperatures
were observed incidentally at seven days post infection
a n da t1 3d a y sp o s ti n f e c t i o n .
Clinical signs started to appear between day six and
seven in all pigs from the PCV2/PRRSV infected group
and also in a number of pigs from the PCV2/PPV infected
group. In the PCV2/PRRSV group the mean clinical score,
based on the occurrence and severity of clinical symptoms,
reached 2.5 (moderate to severe disease) of a maximum
score of 3. In this group severe disease signs started to
develop from seven days post infection on (Figure 1C). In
the PCV2/PPV infected group the manifestation of disease
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score was generally lower in this group. Clinical signs as
severe depression were observed in more than 80% of all
pigs from the PCV2/PRRSV group compared to 10% in
the PCV2/PPV group. Whereas respiratory distress was
recorded in all infected pigs, 75% from the PRRSV co-
infected group showed signs of pneumonia and only about
20% of the PPV co-infected group (Figure 2). A palpable
increase of the size of the inguinal lymph nodes was found
in all PCV2/PRRSV infected pigs from 12 days post infec-
tion on and in three pigs from the PCV2/PPV infected
group from 12, 19 or 21 days post infection on.
At necropsy, typically for PMWS, inguinal lymph nodes
and also other lymph nodes were enlarged in all infected
pigs and the mean weights of the inguinal lymph nodes in
both infected groups were higher than in the control group
(PCV2/PRRSV vs. control, p < 0.03; PCV2/PPV versus con-
trol, p < 0.08). In the PCV2/PRRSV infected group two of
nine pigs had a macroscopically identifiable pneumonia,
although a moderate to severe interstitial pneumonia was
found in eight of nine pigs based on histology. In the
PCV2/PPV infected group macroscopic changes were
restricted to increased size of the inguinal lymph node and
kidney, liver or lung changes in a few pigs. Histologically,
Figure 1 Body weight gain (A), Body temperatures (B) and clinical scores (C) in experimentally infected groups.C o u r s eo ft h eb o d y
weight gain (Figure 1A), body temperature (Figure 1B) and clinical scores (Figure 1C) were recorded in experimental groups of three weeks old,
colostrum-deprived piglets inoculated with either a combination of PCV2 and PRRSV (PCV2/PRRSV), PCV2 and PPV (PCV2/PPV), or phosphate
buffered saline (controls). For each experimental group consisting of eight (PCV2/PPV) or nine animals (PCV2/PRRSV, controls) data were
collected for a period of 26 days post inoculation. Rectal temperatures were measured twice daily and clinical scores were determined based on
a collection of predefined clinical symptoms ranging from no disease (0) to severe disease (3). Arrows (↑) indicate time of sampling for SELDI-
TOF protein profiling.
Koene et al. BMC Veterinary Research 2012, 8:32
http://www.biomedcentral.com/1746-6148/8/32
Page 3 of 14most striking was a slight to moderate hepatitis in seven of
eight pigs. In five of 17 PCV2 infected pigs lymph node
depletion was observed, in others a hyperplasia was more
prominent.
After termination of the experiment, tissue samples were
tested for the presence of PRRSV and PCV2 nucleic acid
detection by PCR. All infected animals showed strong
positive results for PCV2 in lymph nodes, lung and spleen.
Although in control animals no PCV2 nucleic acid was
detected in pharyngeal swabs throughout the study, low
levels of PCV2 nucleic acid were found in single or several
tissue specimens of six control animals. PRRSV nucleic
acid was detected in lungs of all PCV2/PRRSV infected
animals but not of the other groups. No PCR testing has
been performed for PPV.
Acute phase proteins
Results of acute phase proteins levels are summarized
in Figure 3. At day five p.i. levels of acute phase pro-
teins did not differ significantly compared to levels in
sera collected prior to inoculation, except for pig
major protein (PigMAP, p = 0.004) and albumin (p =
0.01) in the control group and PigMAP in the PCV2/
PPV infected group (p = 0.035). More significant dif-
ferences were observed at day 19 p.i. compared to
levels at day zero for three acute phase proteins; hap-
toglobin (Hp) in the PCV2/PRRSV group (p < 0.001),
PigMAP in PCV2/PPV (p = 0.023) and PCV2/PRRSV
infected animals (p = 0.021), and albumin in PCV2/
PPV (p = 0.002), PCV2/PRRSV infected animals (p =
0.003), as well as in the PBS treated control group
(p = < 0.001).
Some statistically significant differences were observed
comparing different experimental groups. At day zero,
PigMAP levels in animals from the PCV2/PRRSV group
(p = 0.013) and a-Lipoprotein (ApoA1) levels in the
PCV2/PPV group (p < 0.001) were significantly different
compared to the control group. At day five p.i., only
ApoA1 (control group versus PCV2/PPV group, p =
0.004), and at day 19 only albumin (control group ver-
sus PCV2/PRRSV group, p = 0.032) were discriminative.
SELDI-TOF proteomics
Serum protein profiles were obtained on day zero as well
as on day five post infection, before clinical symptoms
became apparent. A third set of protein profiles was
obtained at day 19 post infection, when all animals from
both experimental infections showed clear signs of disease.
Using the Protein chip Data Manager software a total of
586 protein peaks were identified and subjected to further
statistical analysis. It should be noted that these 586 pro-
tein peaks may represent a lower number of proteins, as a
certain overlap may be present among the results obtained
with the three types of arrays that have been used.
Protein profiles of serum obtained from all animals prior
to infection (day 0) were tested for differences. No statisti-
cal significant differences could be observed between ani-
mal groups, indicating that in this respect, the three
groups of animals were very similar at the time of
infection.
Overview of comparisons
We performed multiple analyses, comparing the three
experimental groups: animals inoculated with (i) PCV2
Figure 2 Clinical symptoms in experimentally infected groups. The percentage of animals in three weeks old, colostrum-deprived piglets
showing diverse signs of disease. Observations were made twice daily during a time frame of 26 days post inoculation with either a
combination of PCV2 and PRRSV (PCV2/PRRSV), PCV2 and PPV (PCV2/PPV) or phosphate buffered saline (controls).
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PRRSV); and (iii) PBS (controls), at three time points.
An overview of these analyses is given in Table 1. The
comparisons can be categorized as follows: (1) infected
animals (PCV2/PPV together with PCV2/PRRSV) versus
non-infected control animals, (2) PCV2/PPV infected
animals versus control animals or PCV2/PRRSV infected
animals versus control animals, (3) PCV2/PPV, PCV2/
PRRSV, and control animals as three distinct groups to
explore the discriminatory power of serum protein pro-
files to distinguish the different infection models.
For each comparison the number of significantly dif-
ferent protein peaks in their profiles was determined as
well as the classification accuracy. Additionally we tested
whether reducing the number of protein peaks in a pro-
file affected the accuracy of classification. Next to whole
protein profiles consisting of 586 protein peaks, we also
tested profiles with 500, 200, 100, 50, 20, and 10 protein
components. For this, proteins were ranked by signifi-
cance and those with highest significance were selected.
Number of significant different protein peaks
For each comparison the number of significantly different
protein peaks is shown in Table 2. Based on a maximum
p-value of 0.01, the number of differentially expressed
protein components ranged from 15 (PCV2/PPV versus
Figure 3 Acute phase protein levels in experimentally infected groups. Mean levels of C-reactive protein (CRP), serum amyloid A(SAA),
haptoglobin (Hp), pig major protein (PigMAP), a-Lipoprotein (ApoA1), and albumin were determined in three weeks old, colostrum-deprived piglets
inoculated with either a combination of PCV2 and PRRSV (PCV2/PRRSV), PCV2 and PPV (PCV2/PPV), or phosphate buffered saline (controls).
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ber of comparisons, molecular masses of the most signifi-
cant differently expressed protein components are
summarized in Table 3.
As expected, based on the False Discovery Rate (FDR),
which may be more appropriate than p-values as it
accounts for multiple testing, the amount of differen-
tially expressed protein components was reduced. In a
number of analyses, none of the protein components
showed a significantly different expression based on an
FDR < 0.05. In general, more protein components were
differentially expressed comparing PCV2/PRRSV
infected animals versus non-infected control animals as
opposed to PCV2/PPV infected versus control animals
as shown in Table 2. Combining data of day five and
day 19 post infection (p.i.) increased the number of sig-
nificantly differentially expressed protein components.
Two-group classification
Infected animals versus non-infected animals
In this analysis, PCV2/PPV along with PCV2/PRRSV
infected animals were marked as infected, whereas con-
trol animals at day five and day 19 are regarded as non-
infected (Table 1). Classification results are summarized
in Table 4.
At day 19 post infection, both PCV2/PPV and PCV2/
PRRSV infected animals displayed evident signs of ill-
ness with 14 of 15 (Sensitivity (Se) = 93.3%; specificity
(Sp) = 57.1%) infected animals having significantly dif-
ferent serum protein profiles compared to non-infected
animals. Moreover at day five, before any disease symp-
toms were apparent, 14 of 16 (Se = 87.5%; Sp = 66.7%)
infected animals could be recognized based on their
serum protein profiles.
Table 1 Overview of the statistical analyses (A-H) with the accompanying data sets that were used
Analysis Day 5 p.i. Day 19 p.i.
2/3way comparison Day p.i. Control PCV2/
PPV
PCV2/
PRRSV
Control PCV2/
PPV
PCV2/
PRRSV
2-way Infected (A2) versus
non-infected (A1)
5, 19 A1
a A2 A2 A1 A2 A2
PCV2/PPV versus
control
5B 1 B 2
PCV2/PRRSV
versus control
5C 1 C 2
PCV2/PPV versus
control
19 D1 D2
PCV2/PRRSV
versus control
19 E1 E2
PCV2/PPV versus
control
5, 19 F1 F2 F1 F2
PCV2/PRRSV versus control 5, 19 G1 G2 G1 G2
3-way PCV2/PPV,
PCV2/PRRSV,
control
5, 19 H1 H2 H3 H1 H2 H3
a Serum protein profiles of animals in groups with the same code have been clustered for statistical analysis.
Different comparisons (A-H) were carried out, including serum protein profiles of animals from different infection groups and/or time points after infection. SELDI-
TOF-MS profiles were obtained from three week old piglets that were experimentally infected with either a combination of PCV2 and PRRSV (PCV2/PRRSV), PCV2
and PPV (PCV2/PPV), or phosphate buffered saline (controls). Statistical analyses were based on data from day five post infection (p.i.), day 19 p.i., or data from
both days combined as indicated in the table.
Table 2 Overview of the number of significant
differentially expressed protein components in different
analyses
Number of significant proteins
Analysis
a Day p.i. p < 0.01 FDR < 0.05
Healthy versus
diseased
5, 19 49 13
PCV2/PPV versus
control
52 6 1
PCV2/PRRSV versus
control
53 6 1
PCV2/PPV versus
control
19 15 -
PCV2/PRRSV versus
control
19 17 -
PCV2/PPV versus
control
5, 19 19 -
PCV2/PRRSV versus
control
5, 19 59 43
PCV2/PPV,
PCV2/PRRSV, control
5, 19 45 12
a: See Table 1 for description of analysis.
SELDI-TOF-MS protein profiles were generated from three week old piglets
experimentally infected with either a combination of PCV2 and PRRSV (PCV2/
PRRSV), PCV2 and PPV (PCV2/PPV), or phosphate buffered saline (controls).
The number of significantly differentially expressed protein components with
p < 0.01 or with False Discovery Rate (FDR) < 0.05 for different analyses are
indicated.
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increased the classification accuracy; using the 50 (day
five post infection) or 100 (day 19 post infection) most
significant differently expressed proteins resulted in the
highest number of correctly classified animals. When
the number of proteins was further limited to ten, a
decrease in correctly classified animals was observed at
day five (Se = 62.5%;Sp = 44.4%). However at day 19
post infection, profiles based on the ten most significant
proteins could still identify 93% (= Se) of the infected
animals, although only one of the seven non-infected
animals was correctly classified (Sp = 14.3%) (Table 4).
Two-group classification: PCV2/PPV versus control or
PCV2/PRRSV versus control
Serum protein profiles of PCV2/PPV infected animals
were compared with profiles of non-infected control
animals on day five and day 19 using either data from a
single time point or combining data from both days.
Similarly, profiles of PCV2/PRRSV infected animals
were compared with control animals. Results are sum-
marized in Table 5.
With regard to the classification of infected versus non-
infected animals at day five post infection, results were
poor for the PCV2/PPV group as only one of seven (Se =
14.3%; Sp = 55.6%) infected animals could be distinguished
from control animals by profiles consisting of 586 protein
components. The classification performance of serum pro-
tein profiles was much better for PCV2/PRRSV infected
animals (Se = 88%; Sp = 77.8%) at day five post infection.
As expected, overall results were better at day 19 post
infection. Six of eight (Se = 75%; Sp = 28.6%) PCV2/
PPV and five of seven (Se = 71.4%; Sp = 71.4%) PCV2/
PRRSV infected animals could be distinguished from
non-infected control animals by serum protein profiles
using 586 protein components. This reflects the clinical
signs, which were very similar for animals in both
groups at 19 days post infection.
Combining the data of both days slightly increased the
classification accuracy as compared to profiles from
either day five or day 19 post infection. This is especially
true for the control groups as shown in Table 5 (Sp
ranges from 66.7% - 100%).
Again, using a preselection of the most significantly
different protein peaks generally led to comparable or
even better classification accuracy, similarly as described
Table 3 Most significantly differentially expressed protein components as characterized by mass:charge (m/z) value
Analysis
Infected vs controls PCV2/PPV vs
control
PCV2/PRRSV vs control PCV2/PPV,
PCV2/PRRSV, and
control
m/z q-value m/z q-value m/z q-value m/z q-value
5540 0.025 54287 0.055 5540 0.010 5540 0.034
8720 0.032 10602 0.158 8720 0.013 147239 0.034
54287 0.032 8565 0.209 147239 0.014 8720 0.034
8565z 0.032 80028 0.283 17175 0.019 8720 0.034
19966 0.034 8720 0.283 34135 0.019 34135 0.034
14540 0.034 187711 0.283 19966 0.019 54287 0.037
10436 0.037 2357 0.283 17171 0.019 64263 0.037
11021 0.037 10516 0.283 10436 0.019 187711 0.037
10726 0.037 10805 0.283 11021 0.019 5542 0.037
2357 0.042 27621 0.283 5542 0.019 8193 0.037
The ten most significantly differently expressed protein components for four analyses as characterized by mass:charge (m/z) value with their q-value (in Daltons)
are summarized. SELDI-TOF-MS Protein profiles were generated from three week old piglets experimentally infected with either a combination of PCV2 and
PRRSV (PCV2/PRRSV), PCV2 and PPV (PCV2/PPV), or phosphate buffered saline (controls). The figures are based on SELDI-TOF-MS data from day five and 19 post
infection combined. The overlap in protein components within different comparative analyses is due to the use of different SELDI-TOF-MS protein chip arrays.
Table 4 The number of animals correctly classified as
either infected or non-infected
Day 5 p.i. Day 19 p.i.
number of
proteins
components
non-
infected
infected non-
infected
infected
10 4 (9) 10 (16) 1 (7) 14 (15)
20 6 12 3 14
50 7 14 3 14
100 7 12 4 15
200 6 13 4 14
500 6 14 3 14
586 6 14 4 14
The number of correctly classified animals (infected versus non-infected) at
day five and day 19 post infection using increasing numbers of SELDI-TOF-MS
protein components. Serum protein profiles were generated from three week
old piglets experimentally infected with either a combination of PCV2 and
PRRSV (PCV2/PRRSV), PCV2 and PPV (PCV2/PPV), or phosphate buffered saline
(controls). In the top row, for each experimental group the total number of
animals included in the analysis is specified between brackets.
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animals.
Three-group classification
To assess the power of serum protein profiles as a diag-
nostic marker for specific infections, we explored the
classification performance of serum protein profiles to
distinguish between the three distinct animal groups (i)
non-infected control animals, (ii) PCV2/PRRSV and (iii)
PCV2/PPV infected animals) in one analysis, i.e. three-
group classification. As expected, three-group classifica-
tion as shown in Table 6 gave similar results compared
to the two-group classification, but with lower classifica-
tion accuracy.
Table 7 shows the contingency tables for day five and 19
for true disease status and classification based on serum
protein profiling using 50 most significant protein peaks.
At day five, almost all (8/9) PCV2/PRRSV infected animals
were classified correctly. A single PCV2/PRRSV infected
animal was misclassified as PCV2/PPV infected. On the
other hand, only two of seven PCV2/PPV animals were
identified correctly. One was improperly classified as
PCV2/PRRSV infected, while four animals could not be
discriminated from non-infected animals. However at 19
days post infection, five of eight PCV2/PPV infected ani-
mals were accurately classified, while only three of seven
P C V 2 / P R R S Vi n f e c t e da n i m a l sc o u l db ei d e n t i f i e db a s e d
on their serum protein profiles. The other four animals
were misclassified as PCV2/PPV infected. Control animals,
when misclassified, were labeled as PCV2/PPV infected
animals, but never as PCV2/PRRSV infected.
In conclusion, PCV2/PRRSV infected animals could
well be distinguished from control animals as early as
day five, while PCV2/PPV infections were best distin-
guished from non-infected control animals at day 19.
Classification results showed a very high significance at
day five (P < 0.001) and were near significance at day 19
(P = 0.095). It can be concluded that based on SELDI-
TOF protein profiles, at day five post infection PCV2/
PRRSV infected animals are easier to distinguish com-
pared to PCV2/PPV infected animals.
Discussion
Livestock health is an important issue for farmers and
veterinarians as well as for consumers. It has an important
economic drive as it affects productivity. In addition, from
the animal welfare perspective there is a need for para-
meters that can objectively measure abnormalities or dete-
rioration of health, preferably in an early stage of disease.
Although the number of animals involved in this study
w a sr a t h e rs m a l l ,t h i ss t u d ys h o w st h a tS E L D I - T O FM S
profiles of high- and low-abundant serum proteins have
potential as diagnostic markers for early detection of viral
infections in pigs. We also show that classification of ani-
mals using ridge penalized partial least squares analysis of
the protein profiles might be a powerful approach for this.
Table 5 Number of animals correctly classified according to infection status, evaluating two distinct classes
Separate/
combined
number
of used
protein markers
1
Day 5
p.i.
Day 19 p.i. Day 5
p.i.
Day 19
p.i.
PCV2/
PPV
Control PCV2/
PPV
Control PCV2/
PRRSV
Control PCV2/
PRRSV
Control
Separate 10 2 (7) 5 (9) 4 (8) 5 (7) 8 (9) 6 (9) 5 (7) 6 (7)
2 0 2 3 5 58656
5 0 2 5 6 56656
100 2 5 6 3 7 7 5 6
200 1 5 6 3 8 8 4 6
500 1 5 6 2 8 7 5 5
586 1 5 6 2 8 7 5 5
Combined 10 2 (7) 5 (9) 7 (8) 3 (7) 7 (9) 8 (9) 5 (7) 6 (7)
2 0 2 7 6 48865
5 0 2 8 5 67956
100 2 6 6 5 7 9 6 6
200 2 6 8 4 7 9 6 5
500 3 6 7 4 7 8 5 6
586 3 6 7 5 7 9 5 6
The number of correctly classified animals according to infection status (2-way classification), based on serum protein profiles at day five and day 19 post
infection (p.i.). The classification results are presented using either data of each day separately or combined. Protein components were selected based on their
differential expression in piglets infected with PCV2/PPV, PCV2/PRRSV and control piglets, using those with the lowest p-values. In the top row, for each
experimental group the total number of animals included in the analysis is specified between brackets.
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data under standardized experimental conditions. How-
ever, to make a useful and robust multi-marker test
based on protein profiles, test development and valida-
tion should include the use of animals that originate
from different breeds, different farms, different time
points post infection and from animals with different
disease history. Since such factors will create additional
variation in protein profiles, larger sample sizes will be
required. In this respect it is promising that combining
profiles of day five and day 19 resulted in improved clas-
sification accuracies, suggesting that protein fingerprints
of different time points after infection show similarities,
which might be utilized under field conditions when
time of infection varies.
Correlation between SELDI-TOF MS results and clinical
data
The aim of this study was to explore the potential of
quantitative data of high- and low-abundant serum pro-
tein components as measured by SELDI-TOF-MS for
early detection and diagnosis of viral infectious diseases
in pigs. The experimental infection model (true status)
of the animal groups was considered as the golden stan-
dard, which was reflected by representative clinical
signs. The infection status was confirmed by PCR, after
termination of the experiment.
The SELDI-TOF MS serum protein fingerprints reflect
the (pre-)clinical status of the two different disease
courses having a comparable disease outcome. Among
PCV2/PRRSV infected animals, body temperatures rose
after day five post infection, while clinical scores
increased sharply from day six onwards when infected
animals were depressed and showed clear respiratory dis-
tress symptoms. Among PCV2/PPV infected animals
body temperatures started to rise from day six onwards,
while clinical scores did not increase until day seven post
infection, typically consisting only of mild depression. It
can be speculated that for PCV2/PPV infected animals
protein fingerprints taken at day five may have been too
early for diagnostic purposes, in contrast to the PRRSV/
PCV2 infected animals.
Table 6 Number of animals correctly classified according to infection status, evaluating three distinct classes
Day 5 Day 19
number of protein
components
PCV2/PPV Control PCV2/PRRSV PCV2/PPV Control PCV2/PRRSV
10 2 (7) 5 (9) 3 (9) 4 (8) 3 (7) 1 (7)
20 4 6 5 6 3 3
50 2 7 8 5 4 3
100 1 7 6 5 4 3
200 1 7 4 5 4 2
500 2 6 6 5 3 2
586 2 5 6 5 4 2
The number of correctly classified animals according to disease status (3 way classification), based on serum protein profiles consisting of variable number of
protein components. Serum protein profiles were obtained at day five and 19 post infection (p.i.) and data of both time points were combined for the statistical
analysis. Protein components were selected based on their differential expression in piglets infected with PCV2/PPV, PCV2/PRRSV and control piglets, using those
with the lowest p-values. In the top row, for each experimental group the total number of animals included in the analysis is specified between brackets.
Table 7 Contingency table showing the classification results according to infection status, evaluating three distinct
classes
Day 5 p.i.
1 Day 19 p.i.
1
True status True status
PCV2/
PPV
Control PCV2/
PRRSV
PCV2/
PPV
Control PCV2/
PRRSV
Classification
results based
on SELDITOF
MS data
PCV2/PPV 2 2 1 5 3 4
Control 4 7 0 1 4 0
PCV2/PRRSV 1 0 8 2 0 3
1 The p-value of the one-sided Fisher exact test was < 0.001 and 0.095 at day 5 and 19 respectively.
Contingency table for 3-way classification, showing the number of correctly and incorrectly classified animals at day five and 19 post infection (p.i.), respectively.
Classification was based on SELDI-TOF-MS serum protein profiles from piglets at day five and 19 after inoculation with either PCV2/PPV, PCV2/PRRSV or
phosphate buffered saline (controls). Data of both time points were combined for the statistical analysis using 50 preselected protein components. Protein
components were selected on their differential expression, using those with the lowest p-values.
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apparent clinical signs were observed. The low content
of PCV2 viral DNA in tissue samples of some control
animals are considered to have been “false positive” test
results. However it cannot be fully excluded that, in
spite of containment measures during the animal experi-
ment, some level of cross contamination with the PCV2
virus occurred in the control group.
Using a whole-protein profile approach instead of
candidate proteins
In the discovery of biomarkers a targeted approach is often
used, aiming at a selection of predefined biomarkers based
on current knowledge of the biological function of pro-
teins or known associations. An example for such
approach is the use of acute phase proteins for early diag-
nostic markers for infections. As levels of these proteins
change early in the process of infection or tissue trauma,
they have been suggested as suitable biomarkers [15,16].
In the present study, the analysis of acute phase proteins
led to disappointing results (Figure 3). Similar to our
experience, experiments conducted by Heegaard et al.
found large between-animal variation and major differ-
ences in prechallenge concentrations between experimen-
tal groups [16], limiting the use of acute phase proteins as
general disease markers.
As an alternative, we explored a whole protein profile
approach using SELDI-TOF-MS and comparative finger-
print analysis of whole protein profiles present in blood
samples and studied its value for early disease diagnosis.
This approach was chosen because it enables the identifi-
cation and selection of “reactive profiles” without any
prior knowledge of the biological functions of the compo-
nents constituting the profiles. Although knowledge of
biological function of proteins could have additional value
and can be used as biological validation, it is not manda-
tory. Another advantage is that protein profile fingerprints
enable the monitoring of quantitative changes rather than
determining particular threshold levels of individual serum
proteins.
A major challenge in the discovery of protein biomar-
kers from blood is the vast difference in concentration
between high- and low-abundant proteins. With tradi-
tional analysis methods, the high-abundance proteins
usually dominate the proteome profiles, making the identi-
fication of less abundant protein components more chal-
lenging. Different strategies have been developed to
eliminate some of the most abundant proteins from blood
serum or plasma [17]. Here we applied the Proteominer™
fractionation kit from Bio-Rad. It is based on a bead-
bound random peptide library that provides a vast amount
of different binding sites for different proteins. Since there
is only a small number of ligands that can bind to the
same protein, this limits the number of identical high-
abundant protein components that can bind to the bead-
bound library. The combination of depletion, enrichment
and fractionation through the Proteominer™ fractionation
kit used in this study has led to the detection of a high
number of differentially expressed high- and/or low-abun-
dance proteins (as shown in Table 2) underlining the
value of this technique. Focussing on low-abundance pro-
teins, rather than the classical plasma proteins, might be a
more promising approach since low abundant biomarkers
may include proteins that either leak into the plasma from
different tissues as a result of the infection or that play a
role as signal molecules.
Classification of infected versus non-infected animals
T h ed i f f i c u l t yw i t hm u l t i p l ed isease classification is that
large sample sizes are required. Therefore, classifying ani-
mals as infected and not-infected or diseased and not-dis-
eased is probably a first starting point. In this study, no
disease symptoms were yet apparent at day five, except
that a number of pigs in the PCV2/PRRSV group had ele-
vated body temperatures. Notably, 14 of 16 (87.5%)
infected animals could be recognized based on serum pro-
tein profiles. As expected, at day 19 post infection results
were even better (93.3%). Further analysis will have to pro-
vide information whether these differences are due to
inflammatory processes or other viral -host interactions.
From experimental studies increases in IFNg secreting
cells and interleukin 10 have been shown as early as 7 and
10 days post infection, respectively [18-20].
Also classification according to distinct infection models
showed promising results. However, the lower sensitivity
as revealed by Table 6 suggests that classification with
respect of specific infectious diseases will be challenging.
Interestingly, the classification performance on both sam-
ple days for infected animals was superior compared to
non-infected animals. This probably reflects the normal
variation in serum protein profiles among “healthy” ani-
mals which is relatively large compared to infected animals
in this small cohort. Also Batxelli-Molina et al. found
more extensive variation in serum protein profiles from
non-infected animals compared to infected animals [6].
It has been shown that in clinical settings multiple
marker assays have increased sensitivity and specificity
compared to single-marker assays [10]. It may be specu-
lated that increasing the number of markers leads to a
further improvement of the diagnostic performance.
Indeed, the number of protein components that were sta-
tistically significant in differential expression between the
distinct animal groups (as shown in Table 2) correlated
well with the classification accuracy: the higher the num-
ber of significant protein markers between the groups,
the better the classification accuracy. However, our find-
ings also suggest that extending protein profiles to more
than about 20 markers does not substantially increase
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of (preselecting) proteins from whole protein profiles of
586 to the ten most significant differentially expressed
components did only marginally decrease the classifica-
tion accuracy. Also the small number of animals used in
this study limits the power of a high number of proteins
in their contribution to classification accuracy. This indi-
cates that although there might be quite a number of
proteins markers associated with the disease status, per-
formance of profiles seems to be more affected by the
predictive value of individual proteins than by the num-
ber of proteins included in the profile.
Statistical methods
For evaluation of SELDI-TOF data a decision tree method
is frequently used. However, to analyse complete sets of
multiple protein peaks, more sophisticated statistical
methods are required. We used ridge penalized partial
least regression to classify animals, which is superior to
decision tree analysis when there are many proteins con-
tributing to the classification or, in other words, when
many proteins are likely to be different between infected
and non-infected animals. Partial least squares techniques
have also been applied in disease classification in humans
[2,21]. The significance testing of individual proteins was
equivalent to the approach used by Batxelli-Molina et al.
[6] and Barr et al. [5] for testing the significance of pro-
teins in the diagnosis of prion diseases.
In this case, we used one-leave-out cross-validation,
because of the very limited number of animals per class.
Due to the fact that one animal is left out, the unbalance
in animals per disease class may be larger. Nevertheless,
two-group as well as three-group classifications were quite
successful, although with lower accuracy in the latter.
Clearly larger sample sizes are necessary to improve the
classification accuracy to more than 90% sensitivity and
specificity required for diagnostic purposes.
Towards development of biomarkers for livestock health
This study shows the potential of protein profiles in com-
bination with advanced statistical methods to distinguish
infected from non-infected animals, providing etiological
information as well. Such an approach may be valuable in
the diagnosis of infectious diseases in the early stage of
disease. In this study we examined sera from animals
experimentally infected with PCV2 in combination with
either PPV or PRRSV. As shown in Table 3 a number of
protein components were significantly differentially
expressed in multiple comparisons. For instance protein
with mass:charge 8720 was evident in all four analyses.
Such proteins may be regarded as key candidate markers
and further investigation is warranted.
In follow-up studies it would be of interest to explore
the classification of animals according to aetiology, such
as bacterial, viral, and parasitical infections. Also differ-
entiation according to disease stage, i.e. acute versus
chronic or affected organ system could be useful. The
ultimate goal might be the development of assays for
health versus disease as opposed to specific etiologic
agents.
The advances of proteomic technologies and promising
study results have fed the hope to obtain biomarkers for
improved and faster diagnostics. Due to the high costs and
required technical skills, spectrometry has traditionally
been limited to research settings. However, it is now
increasingly used for diagnostic purposes in routine set-
tings for the identification of infectious microorganisms
[15]. SELDI-TOF-MS is a promising tool to determine
protein profiles at medium throughput level and at reason-
able costs. In human medicine, proteomic methods are
increasingly used for early diagnosis of diseases [20]. In
addition, it appears that the challenges of multiplexing
such tests (e.g., on arrays) are sufficiently daunting that
quantitative mass spectrometry may have value as an addi-
tional format for multiplexing protein measurements in
the future given aggressive technology development. A
major disadvantage for mass diagnostics as required in
livestock veterinary medicine is the invasive procedure of
blood sampling to get appropriate test material for analysis
of biomarkers in serum. An alternative for the use of sera
would be to explore the potential of protein profiles in
easy to access biological samples like saliva, urine or
faeces. Also, the recent developments in the field of
micro- and nanotechnology have seen a rapid surge in
interest in electronic devices for medical implants for in
vivo health monitoring. In the human biomedical field sev-
eral promising prototypes are emerging, for example for
monitoring of patients with chronic cardiac or neurologi-
cal diseases [22]. Similar developments may be expected
for the veterinary health care sector.
Conclusions
In this study the potential of quantitative protein profiles
by SELDI-TOF MS for early diagnosis of viral infections in
pigs was explored. Results from serum of pigs experimen-
tally infected with a combination of PCV/PPV and PCV2/
PRRSV indicate that SELDI-TOF protein profiles have
potential for detection of (viral) infection in pigs in early
phase of the disease. The accuracy of classification of
infected versus non-infected animals was good, as 88% of
the infected animals could be classified based on the
serum protein profiles at day five post infection, that is
before clinical symptoms became apparent. At day 19 post
infection, 93% of the infected animals were classified as
such. Results for PCV2/PRRSV were superior compared to
PCV2/PPV infected animals, especially at day five post
infection. The lower specificity, both at day five (67%) and
day 19 post infection (57%), probably reflects the variation
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Limiting the number of proteins in the profile generally
had minor effects on the classification accuracy. Accuracy
of three-way classification was less than that of two-way
classification. It can be concluded that SELDI-TOF MS
protein profiles may have potential as biomarker for early
diagnosis of viral infections in animal husbandry.
Methods
Experimental infection
The animal experiment was according to Dutch law
approved of by the Animal Ethical Committee of CVI
(trial code 2008056c). Animals: Twenty- six, colostrum-
deprived piglets from a conventional breeding line
(TOPIGS 20™) of three weeks of age were housed in
three different animal rooms with HEPA filtered supply
and exhaust air filtration. Piglets were tested negative by
PCR assay for PCV2, PPV and PRRSV prior to start of the
study and allocated to three groups, which were either
inoculated with PBS, or a combination with either PCV2/
PRRSV or PCV2/PPV. Virus inocula: Tissue-culture pro-
pagated PCV2b strain 1324 (2
nd passage), isolated in 2002
i nt h eR e p u b l i co fI r e l a n df r o map o o l e dt i s s u eh o m o g e -
nate from a PMWS diseased animal and PPV strain 1005
(8
th passage) were kindly supplied by Prof. G. Allan, Uni-
versity of Belfast. The 7
th passage of PRRSV strain Ter-
Huurne, a EU-strain of PRRSV, propagated on lung
macrophages was used. The titer of the PCV2 virus inocu-
lum was 2 × 10
5 TCID50/ml, of the PPV virus inoculum
2×1 0
6 TCID50/ml and of the PRRSV virus inoculum 1 ×
10
6 TCID50/ml. On day zero, individual pigs received
either the PBS sham inoculum, or the virus pools in a
volume of three ml each. For this, aerosols of the inocula
were produced by a commercial, gravity-fed, single trigger
airbrush (Evolution™, Harder&Steenbeek, NL) with a
nozzle of 0.2 mm, creating an aerosol with 90% of droplets
smaller than 99 μm in diameter, 50% of droplets smaller
than 50 μm, and 10% droplets smaller than 26 μm. The
aerosol was administered intranasally alternately to each
nostril during inspiration phases. Pigs were weighed
weekly and followed clinically for a period of 27 days after
infection. Rectal temperatures were measured twice daily.
Inguinal lymph nodes were palpated daily to monitor
increase in size and clinical symptoms were recorded by
using pre-defined identifiers. These identifiers or a combi-
nation of identifiers were used to define a clinical score
per day as no disease (0), mild (1), moderate (2) or severe
(3) disease. Serum blood samples were taken from the
external jugular vein at days 0, 2, 5, 7, 9, 12, 15, 19 and 22.
After coagulation, serum was separated by centrifugation
at 2000 g for 10 min. and stored at -80°C until analysis. At
day 27, pigs were euthanized and a full necropsy was per-
formed. Tissue specimens were taken for virus nucleic
acid detection by polymerase chain reaction (PCR) analysis
as described [14]. Briefly, RNA and DNA were extracted
from organ suspensions using the QIAmp blood and tis-
sue kit (Qiagen, Westburg, the Netherlands) for DNA and
the High Pure RNA isolation kit for RNA (Roche diagnos-
tics, Germany) according to the manufacturer’s recom-
mendations. To quantify the amount of PCV2 DNA
copies in organ samples, a real-time fluorescent-probe
PCR with the light-Cycler probes (LC red 640 - ATC TCA
TCA TGT CCA CCG CCC AGG A) (FL fluorescein
-CGT TGT ACT GTG GTA CGC TTG ACA GT) and
the primers (1391; 5’-CTC CCC TGT CAC CCT GGG
TG -3’ and 1577; 5’-CTC TCC CGC ACC TTC GGA
TAT-3’) amplifying a 186-bp fragment from the cap gene
of PCV2 were used. The viral RNA concentration of
PRRSV was assessed by a reverse transcription real time
PCR with the following primers: 5’-GAT GAC RTC CGG
CAY C -3’ (forward); 5’- CAG TTC CTG CGC CTT GAT
-3’ (reverse) exerted on a MX3005 (Stratagene) machine.
Acute phase proteins
The serum concentration of haptoglobin was measured by
use of an assay based on haemoglobin-haptoglobin bind-
ing [23] while serum CRP and pig MAP [24] and SAA
concentrations were assayed by ELISA [16]. The concen-
tration of Apo A1 was determined by radial immunodiffu-
sion [16] and albumin was measured using a dye-binding
assay for this protein on an automated biochemistry analy-
ser (Prestige Analyser, Trio-Diagnostics Ltd, York). Assays
for porcine APP were performed by ReactivLab Ltd, (Glas-
gow, UK).
Serum enrichment and fractionation
To detect the proteins present in low levels it is advisable
to remove the most abundant proteins first [13]. Recently,
a new method for enriching low-abundance proteins has
been commercially available. This technology is known
under de trade name of ProteoMiner
® (BioRad, Veenen-
daal) and is based on the use of a combinatorial peptide
binding library, which affinity-captures and amplifies the
low abundance proteome [12]. ProteoMiner
® treatment
was performed according to manufacturer’s recommenda-
tion. Briefly, 525 mg bulk beads swelled by rehydration
with 10 ml 20% (v/v) aqueous EtOH. 100 μlo ft h i sb e a d s
solution is after washing with water and PBS in a 96-well
filter plate (Pall-5039) mixed with 200 μlc e n t r i f u g e d
serum for two hours at 4°C. After binding and washing
the beads three times with 200 μl PBS, the proteins were
eluted three times with 20 μlo fe a c ho ft h ef o u re l u t i o n
reagents; fraction1 (1 M NaCl, 20 mM HEPES pH7.5),
fraction2 (200 mM glycine pH2.4), fraction3 (60% ethylene
glycol), fraction4 (33% isopropyl alcohol, 16.7% acetoni-
trile, 0.1% TFA). Between every elution the beads where
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1 min at 1000 g to collect the eluent from filter plate to a
collection plate.
Protein profiling
Protein examination was performed according to the
manufacturer’s instructions. Briefly, a volume of 100 μl
of the 10-fold diluted fractions, in appropriate binding
buffer depending of the array, were incubated on the
spots of three type of ProteinChip arrays (BioRad). A
cation exchange (CM10) array with CM10 binding buf-
fer (100 mM sodium-acetate pH 4.0), a copper-coated
IMAC array with IMAC binding buffer (0.1 M sodium
phosphate, 0.5 M NaCl pH7), and a reverse phase (H50)
array with H50 binding buffer (10% acetonitrile, 0.1%
trifluoroacetic acid (TFA)).
After 60 minutes incubation the arrays were washed
three times with 200 μl appropriate binding buffer, fol-
lowed by a wash with 200 μlMilliQ water.
After the arrays were dry, 2 × 1 μl of a saturated solution
of sinapinic acid (SPA) in 50% acetonitrile (v/v), 0.5% tri-
fluoroacetic acid (v/v) was added. The mass spectra of the
proteins captured on the chips were recorded with the
PCS4000 ProteinChip array reader (BioRad) by using Pro-
teinChip Data Manager software 3.5.0.
Previous to the measurements, the mass spectrometer
was checked using the OQ kit (BioRad) for high voltage
conditioning, detector calibration, detector sensitivity,
mass drift, mass resolution, and mass accuracy. For cali-
brating, the All-in-One Protein Standard II (Biorad) was
used.
The resulting protein profiles, obtained from the time-
of-flight mass spectrometry spectra were analysed for
differences in expression using Bio-Rad ProteinChip
Data Manager, version 3.5.0 with the integrated Biomar-
ker Wizard™ cluster analyses software (Biorad). First,
peaks with a signal to noise ratio higher than five were
selected. These were clustered with peaks having similar
masses in other profiles with signal to noise ratios
higher than two. Before cluster analyses, the baseline
was subtracted and profiles were normalized using total
ion current.
Data processing
After the identification of the peaks and normalization
of the profiles, a total of 586 proteins from 26 animals
were subjected to statistical analysis. For a number of
proteins data were unavailable at some time points. Two
animals died during the experiment and only data on
day zero and day five were available. Additionally some
missing values existed for subsets of proteins (e.g. CM10
or IMAC). Animals with absent data on a specific day
were excluded only for that day.
Significance testing proteins
Initially an ANOVA was performed for each protein, to
detect significant differences between disease groups
(PCV2/PPV, PCV2/PRRSV, versus control, or infected ver-
sus uninfected animals) using an F-test. Multiple testing
increases the risk of false positives. To reduce the risk of
false positives, the false discovery rate (FDR) was used.
The FDR was set to 5% and the obtained P-values of the
F-test were converted into so-called q-values using the
package ‘qvalue’ in R [25]. The different comparisons are
listed in Table 1. In addition, we tested also for differences
prior to infection at day zero. No proteins showed signifi-
cant differences between animal groups for any contrast,
confirming that animals of the three experimental groups
were very similar pre-infection.
Classification of animals based on protein profiles
For classification of animals based on expression of several
proteins we used partial least squares with penalized logis-
tic regression [26]. The method combines partial least
squares with logistic regression. Partial least squares is
both a tool for linear regression and a tool for dimension
reduction [27] as we have more explanatory variables, i.e.
proteins, than observations. Logistic regression is a com-
mon method for binary data using generalized linear mod-
els. The method used here combines both and makes it a
suitable method for predicting to which categories animals
belong based on many predictors [26]. Combining logistic
regression with partial least squares has been also applied
to disease classification in humans [28]. Here we used the
functions rpls (for two-group classification) and mrpls (for
three-group classification) from R-package plsgenomics
[26]. The parameters lambda and the number of latent
variables were determined using cross-validation. The
ridge partial least squares method was applied in two
ways: 1. by using all proteins and 2. by preselecting the top
n proteins with the lowest p-values of ANOVA.
To assess the accuracy of classification we performed a
leave-one-out cross-validation, so that every record was
left out once from the training set and was predicted
based on the others being in the training set. When we
used data of different days all records of one animal were
used as validation set and the remaining as training set to
prevent that the animal itself could have one record as
training and another in the validation set. When using
preselected proteins, the significance was based on the
training set only to prevent the data from the validation
animal effecting the preselection of proteins.
Data from day five and day 19 were used both sepa-
rately and combined for analyses concerning two-group
classification (that is distinguishing either infected from
non-infected animals, or animals from each disease
group (PCV2/PPV, PCV2/PRRSV) versus control ani-
mals). For the three-group classification data of day five
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Page 13 of 14and 19 were combined. The accuracy of classification
was given as number of correctly identified animals. In
addition, sensitivity and specificity were calculated for
two-way classifications, but not for three-way classifica-
tions because sensitivity and specificity are not suitable for
that situation. All analyses are summarized in Table 1.
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